Leman Biotech reposted this
Leman Biotech will present the results of the IIT clinical trials on investigating Meta 10-19 CAR-T cell therapy for relapsed or refractory CD19+ B cell hematological malignancies at AACR 2024. The oral presentation (3:50 pm to 4:05 pm) will be part of the Minisymposium Late-Breaking Research Session scheduled at 2:30 pm to 4:30 pm, April 8, 2024. You are welcome to join us then! #AACR #AACR2024 #Cellandgenetherapy #clinicaltrials #celltherapy #CART #CARTtherapy #leukemia #lymphoma #hematology #hematologicalmalignancies #immunometabolism
